covaxin

NEW DELHI: The Indian vaccine market, which has carved out a place for itself at the global level, is expected to reach a valuation of Rs 252 billion by 2025, Union Minister Jitendra Singh has said. The minister, who is on an official visit…

“Covaxin is available for supplies based on demand,” said Bharat Biotech as Covid-19 cases rise in India. File Photo. | Photo Credit: Reuters Covaxin maker Bharat Biotech will wait and watch the demand before resuming production of the…

…

Image for representational purposes only. | Photo Credit: The Hindu Hyderabad-based Bharath Biotech said Tuesday that its nasally administered vaccine, iNCOVACC, would be available for public use from the fourth week of January and cost…

…

…

The Indian government has likely approved Biological E's Corbevax as a precaution dose for those above 18 years of age who are fully vaccinated with either Covishield or Covaxin, official sources told news agency PTI. This is for the first…

…

NEW DELHI : The National Technical Advisory Group on Immunisation (NTAGI) is to meet in June to review Covid immunisation data for children between 5-12 years of age and firm up vaccination protocols. Previous…

Observing that the Court cannot sit in judgement of leading scientific analysis relating to the safety of paediatric vaccination, the Supreme Court has said that the decision taken by the Centre to vaccinate children in the country is in…